1. Home
  2. Labeler Index
  3. Uriel Pharmacy Inc.
  4. NDC Product Code: 48951-2132 Bismuth Stibium

NDC 48951-2132 Bismuth Stibium

Ointment Topical - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 48951-2132?
  4. Bismuth Stibium Uses
  5. Active Ingredients
  6. Pharmacologic Classes

Product Information

NDC Product Code:
48951-2132
Proprietary Name:
Bismuth Stibium
Non-Proprietary Name: [1]
Bismuth Stibium
Substance Name: [2]
Antimony; Bismuth; Chelidonium Majus; Garlic; Thuja Occidentalis Whole; Turmeric
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route(s): [4]
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
    • Labeler Name: [5]
    Uriel Pharmacy Inc.
    Labeler Code:
    48951
    Product Label ID:
    2cb49bd7-529e-404e-a11f-10af464d7174
    Marketing Category: [8]
    UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
    Start Marketing Date: [9]
    09-01-2009
    Listing Expiration Date: [11]
    12-31-2025
    Exclude Flag: [12]
    N
    Code Structure:
    Code Navigator:

    Product Packages

    NDC Code 48951-2132-5

    Package Description: 60 g in 1 TUBE

    Product Details

    What is NDC 48951-2132?

    The NDC code 48951-2132 is assigned by the FDA to the product Bismuth Stibium which is a human over the counter drug product labeled by Uriel Pharmacy Inc.. The product's dosage form is ointment and is administered via topical form. The product is distributed in a single package with assigned NDC code 48951-2132-5 60 g in 1 tube . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Bismuth Stibium?

    Directions: FOR TOPICAL USE ONLY.

    What are Bismuth Stibium Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
    • ANTIMONY 2 [hp_X]/g - A metallic element that has the atomic symbol Sb, atomic number 51, and atomic weight 121.75. It is used as a metal alloy and as medicinal and poisonous salts. It is toxic and an irritant to the skin and the mucous membranes.
    • BISMUTH 2 [hp_X]/g - A metallic element that has the atomic symbol Bi, and atomic number 83. Its principal isotope is Bismuth 209.
    • CHELIDONIUM MAJUS 1 [hp_X]/g - A plant species of the family PAPAVERACEAE. The common name greater celandine is similar to lesser celandine (Ficaria verna), and celandine poppy (Stylophorum diphyllum). It has been used in folk medicine and its latex contains biologically active compounds including BENZOPHENANTHRIDINES alkaloids (e.g., Chelerythrine).
    • GARLIC 1 [hp_X]/g - A species of Allium used as a spice (SPICES) and traditional remedy. It contains alliin lyase and alliin, which is converted by alliin lyase to allicin, the pungent ingredient responsible for the aroma of fresh cut garlic.
    • THUJA OCCIDENTALIS WHOLE 1 [hp_X]/g
    • TURMERIC 1 [hp_X]/g

    Which are the Pharmacologic Classes for Bismuth Stibium?

    A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".